FierceBiotech5h
Roche bets up to $1B to expand Dyno gene therapy delivery pact
After forming a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more. | In a new deal potentially ...
Dyno signs second Roche deal worth over $1B
George Church-founded Dyno Therapeutics Inc. is adding to its list of pharma deals by signing a second research collaboration ...
BioSpace5h
Roche Inks Potential $1B Gene Therapy Deal With Dyno, Eyes Neurological Diseases
With an upfront payment of $50 million from Roche, the partnership will leverage Dyno Therapeutics’ in vivo gene therapy ...
Roche Confirms Profit Forecast as Sales Beat Estimates
Roche said it would increase its dividend after its hemophilia injection Hemlibra and multiple sclerosis treatment Ocrevus ...
Roche CEO Says More People Have Mpox in Europe Than Has Been Reported
FRANKFURT (Reuters) - The CEO of Roche said more cases of mpox infection have likely occurred in Europe than previously ...
Roche Q3 sales advance by forex-adj 9%, beating market view
Roche's third-quarter sales gained a currency-adjusted 9%, beating market expectations, on higher prescriptions of ...
FierceBiotech2d
Roche tosses out tau prospect, returning rights to UCB 4 years after placing $120M bet
Roche has returned the rights to UCB’s anti-tau antibody bepranemab, walking away from a $120 million bet on the Alzheimer’s ...
FiercePharma1d
Roche's Vabysmo will rise above Eylea biosim threat, exec says, as DMD gene therapy Elevidys delivers sales surprise
By squeezing Regeneron’s Eylea, eye disease drug Vabysmo has become one of the biggest growth drivers for Roche. | Despite ...
BioSpace1d
Roche Beats Q3 Sales Estimates as CEO Voices Opposition to Novo Holdings’ Catalent Buyout
Jefferies analyst Peter Welford noted that Roche’s pharma group came just slightly ahead of consensus expectations, driven by ...
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
Roche reported a 9% increase in third-quarter sales, driven by strong performance from Ocrevus and Vabysmo. Roche also raised ...
Roche CEO: We can see the strong underlying growth we have in our business
NFL News: Andy Reid's Chiefs sign a key veteran to help Patrick Mahomes, Travis Kelce The Ocean Has Massive Energy Reserves.